Law of nature: Some genetic diagnostic methods are patent-ineligible

Description

Abstract: Another patent covering genetic diagnostic methods has failed the U.S. Supreme Court’s two-step test for determining whether a patent related to a law of nature is patent-eligible. This article discusses Genetic Technologies Ltd. v. Merial L.L.C. The Federal Circuit Court weighed whether the claim at issue related to a patent-ineligible concept and whether the patent included an “inventive concept.” Genetic Technologies Ltd. v. Merial L.L.C., Nos. 2015-1202, 2015-1203, April 8, 2016 (Fed. Cir.) Ariosa v. Sequenom, Nos. 2014-1139, 2014-1144, June 12, 2015 (Fed. Cir.) Mayo Collaborative Services v. Prometheus Laboratories, Inc., No. 10–1150, March 20, 2012 (U.S.)